186 related articles for article (PubMed ID: 33355369)
1. JNK‑IN‑8 treatment alleviates lipopolysaccharide‑induced acute lung injury via suppression of inflammation and oxidative stress regulated by JNK/NF‑κB signaling.
Du J; Wang G; Luo H; Liu N; Xie J
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355369
[TBL] [Abstract][Full Text] [Related]
2. Linarin prevents LPS‑induced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NF‑κB pathways.
Han X; Wu YC; Meng M; Sun QS; Gao SM; Sun H
Int J Mol Med; 2018 Sep; 42(3):1460-1472. PubMed ID: 29845284
[TBL] [Abstract][Full Text] [Related]
3. Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway.
Zhang R; Guo N; Yan G; Wang Q; Gao T; Zhang B; Hou N
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649807
[TBL] [Abstract][Full Text] [Related]
4. Structured triglyceride attenuates lung injury and inflammation in lipopolysaccharide‑induced acute lung injury by enhancing GPR120 expression.
Sun H; Pang Y; Zhao D; Li W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880584
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner.
Huang XT; Liu W; Zhou Y; Hao CX; Zhou Y; Zhang CY; Sun CC; Luo ZQ; Tang SY
Int J Mol Med; 2019 Dec; 44(6):2213-2222. PubMed ID: 31661121
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway.
Fu S
Int J Mol Med; 2020 Jul; 46(1):131-140. PubMed ID: 32626914
[TBL] [Abstract][Full Text] [Related]
7. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
Pei X; Zhang XJ; Chen HM
Biochem Biophys Res Commun; 2019 Aug; 516(1):270-277. PubMed ID: 31248593
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑κB signaling pathway.
Gao H; Xiao D; Gao L; Li X
Int J Mol Med; 2020 Aug; 46(2):561-570. PubMed ID: 32468034
[TBL] [Abstract][Full Text] [Related]
9. miR‑26a‑5p alleviates lipopolysaccharide‑induced acute lung injury by targeting the connective tissue growth factor.
Li H; Yang T; Fei Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179083
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑129 plays a protective role in sepsis‑induced acute lung injury through the suppression of pulmonary inflammation via the modulation of the TAK1/NF‑κB pathway.
Yao W; Xu L; Jia X; Li S; Wei L
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34080641
[TBL] [Abstract][Full Text] [Related]
11. Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK/NF-κB signaling pathway.
Li T; Wu YN; Wang H; Ma JY; Zhai SS; Duan J
Mol Immunol; 2020 Apr; 120():13-22. PubMed ID: 32045770
[TBL] [Abstract][Full Text] [Related]
12. AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway.
Wang X; Yang B; Li Y; Luo J; Wang Y
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34590152
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of propofol on experimental neonatal acute lung injury.
Yu X; Li C
Mol Med Rep; 2019 May; 19(5):4507-4513. PubMed ID: 30942421
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation.
Liu H; Lin Z; Ma Y
Biomed Pharmacother; 2020 May; 125():109943. PubMed ID: 32106380
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor α‑induced protein 8‑like 2 contributes to penehyclidine hydrochloride pretreatment against lipopolysaccharide‑induced acute lung injury in a mouse model.
Yuan M; Jing G; Kong Q; Ming T; Song X; Wu X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468006
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human brain natriuretic peptide attenuates LPS-induced cellular injury in human fetal lung fibroblasts via inhibiting MAPK and NF-κB pathway activation.
Song Z; Zhao X; Liu M; Jin H; Cui Y; Hou M; Gao Y
Mol Med Rep; 2016 Aug; 14(2):1785-90. PubMed ID: 27314600
[TBL] [Abstract][Full Text] [Related]
17. Allicin attenuates lipopolysaccharide‑induced acute lung injury in neonatal rats via the PI3K/Akt pathway.
Wang X; Zhang C; Chen C; Guo Y; Meng X; Kan C
Mol Med Rep; 2018 May; 17(5):6777-6783. PubMed ID: 29512749
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway.
Zhang Z; Chen N; Liu JB; Wu JB; Zhang J; Zhang Y; Jiang X
Mol Med Rep; 2014 Jul; 10(1):101-6. PubMed ID: 24818579
[TBL] [Abstract][Full Text] [Related]
19. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of diphenyleneiodonium, an NADPH oxidase inhibitor, on lipopolysaccharide-induced acute lung injury.
Kim SK; Rho SJ; Kim SH; Kim SY; Song SH; Yoo JY; Kim CH; Lee SH
Clin Exp Pharmacol Physiol; 2019 Feb; 46(2):153-162. PubMed ID: 30403294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
